117 related articles for article (PubMed ID: 38665026)
1. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated Cancer (CAC).
Sun A; Ge J; Ding K; Gao Z; Zhang Y
Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
3. Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.
Cui H; Jin Y; Wang N; Liu H; Shu R; Wang J; Wang X; Jia B; Wang Y; Bian Y; Wen W
Phytomedicine; 2024 Jun; 128():155509. PubMed ID: 38452403
[TBL] [Abstract][Full Text] [Related]
4. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
[TBL] [Abstract][Full Text] [Related]
5. [Banxia Xiexin Decoction inhibiting colitis-associated colorectal cancer infected with Fusobacterium nucleatum by regulating Wnt/β-catenin pathway].
Jiang YF; Huang YQ; Hu YE; Yang Y; Zheng C; You FM; Zhao ZY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1266-1274. PubMed ID: 38621974
[TBL] [Abstract][Full Text] [Related]
6. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.
Liu ZY; Zheng M; Li YM; Fan XY; Wang JC; Li ZC; Yang HJ; Yu JM; Cui J; Jiang JL; Tang J; Chen ZN
Theranostics; 2019; 9(12):3659-3673. PubMed ID: 31281505
[No Abstract] [Full Text] [Related]
7. Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.
Wang J; Ding K; Wang Y; Yan T; Xu Y; Deng Z; Lin W; Zhang L; Zhu W; Zhao R; Zhou Y; Liu Z
Oxid Med Cell Longev; 2022; 2022():4061713. PubMed ID: 35927991
[TBL] [Abstract][Full Text] [Related]
8. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice.
Wang X; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
Int Immunopharmacol; 2020 Jul; 84():106531. PubMed ID: 32353687
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer.
Bai B; Wu F; Ying K; Xu Y; Shan L; Lv Y; Gao X; Xu D; Lu J; Xie B
Theranostics; 2021; 11(13):6225-6239. PubMed ID: 33995655
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
[TBL] [Abstract][Full Text] [Related]
11. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy.
Sheng YH; Giri R; Davies J; Schreiber V; Alabbas S; Movva R; He Y; Wu A; Hooper J; McWhinney B; Oancea I; Kijanka G; Hasnain S; Lucke AJ; Fairlie DP; McGuckin MA; Florin TH; Begun J
Cell Mol Gastroenterol Hepatol; 2021; 11(1):33-53. PubMed ID: 32497793
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway.
Tan G; Huang C; Chen J; Zhi F
J Hematol Oncol; 2020 Nov; 13(1):149. PubMed ID: 33160389
[TBL] [Abstract][Full Text] [Related]
13. An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer.
Kuai Y; Liu H; Liu D; Liu Y; Sun Y; Xie J; Sun J; Fang Y; Pan H; Han W
Theranostics; 2020; 10(15):6743-6757. PubMed ID: 32550901
[TBL] [Abstract][Full Text] [Related]
14. MiR-597-5p inhibits carcinogenesis and macrophage recruitment in colitis-related colorectal cancer via reducing the expression of CXCL5.
Li S; Yu M; Wang X; Fei B
Cancer Biol Ther; 2023 Dec; 24(1):2274122. PubMed ID: 37942533
[TBL] [Abstract][Full Text] [Related]
15. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
16. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
[TBL] [Abstract][Full Text] [Related]
17. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice.
Liu M; Xie W; Wan X; Deng T
Int Immunopharmacol; 2020 Nov; 88():106862. PubMed ID: 32771947
[TBL] [Abstract][Full Text] [Related]
18. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
[TBL] [Abstract][Full Text] [Related]
19. Anti-Obesity Drug Orlistat Alleviates Western-Diet-Driven Colitis-Associated Colon Cancer via Inhibition of STAT3 and NF-κB-Mediated Signaling.
Jin BR; Kim HJ; Sim SA; Lee M; An HJ
Cells; 2021 Aug; 10(8):. PubMed ID: 34440829
[TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
Niu W; Wu Z; Wang J; Zhang H; Jia W; Yang M; Luo Y; Zhang X
Dig Dis Sci; 2018 Sep; 63(9):2341-2350. PubMed ID: 29796912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
